USPTO serial 79375208
BIONDD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 5, 2025
- Examiner
- FLETCHER, TRACY L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIONDD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Olivia M. Clavio
Olivia M. Clavio FAEGRE DRINKER BIDDLE & REATH LLP300 N. Meridian St., Ste. 2500Indianapolis, IN 46204United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Ingestible drug delivery agents in the form of capsules filled with pharmaceutical preparations for the treatment of cardiovascular disease, cancerous diseases, joint diseases, infectious diseases, gastrointestinal diseases, ocular disorders and diseases, bacteria-based diseases and disorders, autoimmune diseases and disorders, kidney diseases and disorders, bone diseases, diabetes, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, respiratory diseases and disorders, and immune system related diseases and disorders | ACTIVE | — |
| 010 | Medical apparatus and instruments for use in endovascular procedures; Drug delivery devices sold empty, in the nature of self-implanting endovascular spikes, contained within ingestible dissolvable capsules, for medical, dental or veterinary use; Ingestible devices for use in medical diagnosis and treatment, namely, capsule endoscopes for medical purposes | ACTIVE | — |
| 042 | Scientific research for medical purposes; medical laboratory services; consultancy relating to product research and development in the field of ingestible devices; laboratory research services relating to oral delivery devices for pharmaceuticals that cannot be absorbed from an ordinary tablet or capsule; scientific research and product development; research and development of new products; clinical research in the field of pharmaceuticals; biological research and medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biograil ApS
- Other trademarks owned by Biograil ApS
- Other trademarks owned by Biograil ApS
- Other trademarks owned by Biograil ApS
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named BIONDD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 13, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 13, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 5, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 5, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 5, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 17, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 17, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 11, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 13, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 12, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 12, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 21, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 10, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 25, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 25, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 28, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 28, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 28, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 29, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 29, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 29, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 29, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 10, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 9, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 1, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 28, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 27, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |